Categories AlphaGraphs, Consumer, Earnings

Infographic: Highlights of JD.com’s (JD) Q1 2022 earnings report


China-based e-commerce firm JD.com Inc. (NASDAQ: JD) Tuesday reported an 18% growth in first-quarter revenues, which translated into a modest increase in adjusted earnings. The impressive performance reflects the steady expansion of the company’s user base.

JD.com Q1 2022 earnings infographic

On an adjusted basis, earnings increased 2% year-over-year to $0.40 per ADS. on an unadjusted basis, it was a net loss of $472 million or $0.30 per ADS, which marked a deterioration from the prior-year period when the company reported a profit.

At $37.8 billion, first-quarter revenues were up 18% from the corresponding period of 2021. At the end of March 2022, JD.com had a total of 580.5 million active customer accounts, up 16% year-over-year.


Check this space to read JD.com’s Q1 2022 Earnings Call Transcript


“We are encouraged to see user engagement metrics continue to improve, demonstrating our strengthened brand image and expanded consumer mindshare. We have been implementing disciplined financial control policies while sparing no effort to support our consumers and business partners in this challenging time. Looking ahead, we will continue to execute our business strategies and focus on delivering sustainable high-quality growth in the years ahead” said Sandy Xu, Chief Financial Officer of JD.com.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top